Information  X 
Enter a valid email address

Brewin Dolphin Hldgs (BRW)

  Print          Annual reports

Thursday 17 June, 2021

Brewin Dolphin Hldgs

Directorate Change

RNS Number : 2476C
Brewin Dolphin Holdings PLC
17 June 2021

LEI : 213800PS7FS5UYOWAC49

 17 June 2021


Brewin Dolphin Holdings PLC (the 'Company')

Appointment of Non-Executive Director


Brewin Dolphin Holdings PLC announces the appointment of Joanna Hall to its Board as a Non-Executive Director. She joins with effect from 16 June 2021 and will sit on the Remuneration and  Nomination committees.

She is currently a Non-Executive director of the Chorley and District Building Society and was previously interim Marketing and Innovation Director at AXA Health and a director at Evaristo Ltd and North Highland Worldwide Consulting.  She is Chartered Institute of Marketing qualified and digital marketing certified with over 30 years' experience in financial services covering business and distribution strategy, proposition development and associated go-to-market activities.

Toby Strauss, Chairman of the Company, said "I am very pleased to welcome Joanna to the Board. She brings great commercial, digital and financial services experience and we look forward to working with her."


There are no further matters to be disclosed in respect of her appointment under Listing Rule 9.6.13R.



For further information:

Tiffany Brill, Group Company Secretary,  0203 201 3208  




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t